Pharmafile Logo
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • - PMLiVE
  • Communiqué 53 Cover Image

New syndicated reports now available

May 11, 2023 | Living with, Patient reports, Syndicated 

Living with CD, PsO, IPF & PF-ILD 2023

Living with Crohn’s Disease (CD) covers 4EU+UK and Japan. Living with Psoriasis (PsO) covers the 4EU+UK. Living with Idiopathic Pulmonary Fibrosis (IPF) & Progressive Fibrosing Interstitial Lung Disease (PF-ILD) covers the US, 4EU+UK and China.

These new syndicated reports are based on quantitative and qualitative market research with patients and are available to purchase. The methodologies for all reports consist of 30-minute online interviews and 40-minute qualitative tele-depth interviews with patients, including a patient-diary exercise.

The reports are designed to provide an in-depth understanding of the patient journey, from diagnosis through to ongoing management of the condition. Through these reports, you will understand how patients’ lives are impacted physically and emotionally, what impacts treatment decision-making and satisfaction, and what unmet needs patients have related to their condition.

The Living With team at Research Partnership is continually expanding the reports to cover a large range of therapy areas and markets. To find out more about other upcoming reports, request an information pack, or arrange a meeting to discuss therapy areas of interest please contact us now.

Head of Living With, Mariel Metcalfe commented, “Research Partnership is committed to producing research which focuses on the voice of the patient, and to offer a more patient-centric view of what it is like to live with a long-term, life-changing illness. Our reports cover a wide range of therapy areas from Autoimmune, Dermatology, Gastroenterology and Respiratory, and we hope to expand the list of therapy areas year on year.”

Find out more about our Living With reports here

This content was provided by Inizio

Company Details

- PMLiVE

Inizio

Email
Website

 Latest Content from  Inizio 

Eyeforpharma Real World Evidence Conference Round up 2018

Earlier this month, APAC Director Pei Li Teh attended Asia’s 11th Eyeforpharma conference in Tokyo, Japan with a focus on Real World Evidence (RWE)This year has seen a turning point...

PEGASUS SCOOPS TWO AWARDS AT COMMUNIQUÉ 2018 FOR ITS ‘SMALL TALK SAVES LIVES’ CAMPAIGN

Pegasus was also highly commended for Communiqué Agency of the Year 2018Pegasus, an Ashfield company, part of UDG Healthcare plc, is delighted to have won the Excellence In Public Health...

PEGASUS OPENS THE HEALTHCARE INSIGHTS STAGE AT CANNES LIONS

Integrated communications agency, Pegasus opened the Healthcare Insights Stage at Cannes Lions today (Monday 18th June) with a speech that explored how organisations and academics can work better together to...

EphMRA Annual Conference 2018

Visit us on stand number 20

Live from Singapore: Full speed ahead – Unlock the full potential of your brand tracking

Thursday 28th June 16:00 SGT/ 16:00 CST / 17:00 JST

Connected Patients – Adopting a patient-centric approach in emerging markets

The concept of patient centricity and putting the patient at the heart of care is being widely adopted by the healthcare industry – the general consensus being that it’s going...

Combination therapies in oncology: The benefits of integrated insights

14 June 2018 11am EDT | 8am PDT | 4pm BST | 5pm CE

Intellus round up 2018

Earlier this month, US President Harriet Kozak and Emerging Markets Director Rachel Howard attended the inaugural Intellus Worldwide Summit in Philadelphia

Janssen & Research Partnership win prestigious BHBIA Best Business Impact award

We are delighted to announce that Janssen and Research Partnership have won the BOBI (Best of Business Intelligence) Award in the Best Business Impact category at the BHBIA annual conference in London for our collaborative market research...

PEGASUS PHARMA TEAM GOES FROM STRENGTH TO STRENGTH WITH NEW APPOINTMENTS AND SENIOR PROMOTIONS

Growth trend continues at Pegasus with six new appointments and five promotions in the Pharma and Life Sciences team